Is metabolic syndrome a discrete entity in the general populaton? Evidence from the caerphilly and speedwell population studies

Heart

Volumn 79, Issue 3, 1998, Pages 248-252

  Yarnell, J W G ^a,d   Patterson, C C ^a   Bainton, D ^c   Sweetnam, P M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Formerly: MRC Epidemiology Unit   (United Kingdom)

^c ANEURIN BEVAN UNIVERSITY HEALTH BOARD   (United Kingdom)

^d Institute of Clinical Science   (United Kingdom)

Author keywords

Epidemiology; Insulin resistance; Ischaemic heart disease; Metabolic syndrome; Screening

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYNDROME; UNITED KINGDOM;

EID: 0031898535     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.3.248     Document Type: Article

References (39)

1. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-605.
3. Flier JS. An overview of insulin resistance. In: Moller DE, ed. Insulin resistance. Chichester: Wiley, 1993.
4. Modan M, Halkin H, Fuchs Z, et al. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 1985;75:809-17.
5. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
6. Haffner SM, Valdez RZ, Hazuda HP, et al. Prospective analyses of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:716-22.
7. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.
8. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa heart study. Circulation 1996;93:54-9.
9. Reaven GM. Syndrome X: 6 years later. J Intern Med 1994; 236 (suppl 736):13-22.
10. Yarnell JWG, Sweetnam PM, Marks V, et al. Insulin in ischaemic heart disease: are associations mediated by triglyceride levels? The Caerphilly prospective study. Br Heart J 1994;71:293-6.
11. Yarnell JWG, Pickering JE, Elwood PC, et al. Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 1994;47:383-8.
12. Bainton D, Miller NE, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J 1992;68: 60-6.
13. Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis: theory and practice. Cambridge: MIT Press, 1975.
14. Rose G, Reid DD, Hamilton PJS, et al. Myocardial ischaemia, risk factors and death from coronary heart disease. Lancet 1977;ii:105-9.
15. World Health Organisation Study Group. Diabetes mellitus. WHO Tech Rep Ser 1985:no 727.
16. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.
17. Perry IJ, Wannamethee SG, Whincup PH, et al. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 1996;144:224-34.
18. Ducimetière P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease in a middle-aged population. Diabetologia 1980;19:205-10.
19. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease. Paris prospective study. Diabetes Care 1991;14: 461-9.
20. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris prospective study, 15-year follow up. Diabetologia 1991;34:356-61.
21. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:131-41.
22. Pyörälä K, Savolainen E, Kaukola S, et al. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2 year follow-up of the Helsinki policemen study population. Acta Med Scand 1985;701(suppl):38-52.
23. Després J-P, Lamarche B, Mauriège P, et al. Hyperinsulinaemia as an independent risk factor for ischaemic heart disease. N Engl J Med 1996;334:952-7.
24. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2: 154-60.
25. Cullen K, Stenhouse NS, Wearne KL, et al. Multiple regression analysis of risk factor for cardiovascular disease and cancer mortality in Busselton, Western Australia - 13 year study. Journal of Chronic Diseases 1983;36:371-7.
26. Hargreaves AD, Logan RL, Elton RA, et al. Glucose tolerance, plasma insulin, HDL-cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis 1992;94:61-9.
27. Welin L, Eriksson H, Larsson B, et al. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992;35:766-70.
28. Orchard TJ, Eichner J, Kuller LH, et al. Insulin as a predictor of coronary heart disease: interaction with apo E phenotype. A report from MRFIT. Ann Epidemiol 1994;4: 40-9.
29. Rewers M, Shetterly SM, Baxter J, et al. Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW): the San Luis Valley diabetes study [abstract]. Circulation 1992;85:865.
30. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo study, 1984 1991. Am J Epidemiol 1994; 140:857-69.
31. Fuller JH, Shipley MJ, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 1983;287:867-80.
32. De Courten M, Zimmet P. Screening for non-insulin-dependent diabetes mellitus. Where to draw the line? Diabet Med 1997;14:95-8.
33. Wiener K. Fasting plasma glucose as a screening test for diabetes mellitus. Diabet Med 1997;14:711-12.
34. Rudenski AS, Matthews DR, Levy JC. Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 1991;40:908-17.
35. Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet 1995;346:120-1.
36. Yarnell JWG, Patterson CC, Sweetnam PM. Simple measure of insulin resistance. Lancet 1995;346:1108-9.
37. Williams B. Insulin resistance: the shape of things to come. Lancet 1994;344:521-4.
38. Elwood PC, Jacobs A, Pitman RG, et al. Epidemiology of Patterson-Kelly syndrome. Lancet 1964;ii:716-20.
39. Taskinen M-R. Strategies for the diagnosis of metabolic syndrome. Curr Opin Lipidol 1993;4:434-43.